Loading clinical trials...
Loading clinical trials...
Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers - Investigator and Subject Satisfaction
The aim of this study is to assess performance and tolerance as well as investigator and subject satisfaction linked to the global management of facial rejuvenation with a new range of hyaluronic acid dermal fillers.
The range of fillers tested in this study includes 5 different hyaluronic acid dermal fillers: Emervel Touch, Emervel Classic, Emervel Deep, Emervel Volume and Emervel Lips. The study will last 6 month. Injections will be performed at baseline. If necessary, the investigator will perform touch-up injections at the following visit (3 weeks later). Investigator and subject satisfaction will be collected through questionnaires.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Galderma investigational site
Arras, France
Galderma investigational site
Nice, France
Galderma investigational site
Paris, France
Galderma investigational site
Berlin, Germany
Galderma investigational site
Darmstadt, Germany
Start Date
March 1, 2010
Primary Completion Date
November 1, 2010
Completion Date
February 1, 2011
Last Updated
March 10, 2021
77
ACTUAL participants
hyaluronic acid dermal fillers
DEVICE
Lead Sponsor
Galderma R&D
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03286283